← FDA Drug Approvals (Drugs@FDA)

REVEX

NDA · New Drug Application · Sponsor: HIKMA · Approved 1995-04-17

Drug application

FDA Application #

NDA020459

Application type

New Drug Application

Brand name

REVEX

Generic name

Nalmefene Hydrochloride

Active ingredients

NALMEFENE HYDROCHLORIDE

Dosage form

SOLUTION

Route

INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

Marketing status

Discontinued

Sponsor

HIKMA

First approval

1995-04-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown